Pulse Biosciences, Inc. (PLSE) Misses Q4 EPS by 7c

Pulse Biosciences, Inc. (NASDAQ: PLSE) reported Q4 EPS of ($0.31), $0.07 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Pulse Biosciences, Inc. (PLSE) click here.

You May Also Be Interested In

• Walmart (WMT) Tops Q2 EPS by 7c, Beats on Revenue; Offers FY27 EPS Guidance
• Baosheng signs non-binding MOU with 58.com for AI marketing
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance